High Risk of Relapse with Intermediate Dose Cytarabine for Consolidation in Young Favorable Risk AML Patients Following Induction with 7+ 3

Bhaskar C Kolla, NAA Halim, Daniel J Weisdorf, Fiona He

Research output: Contribution to conferenceAbstract

Original languageEnglish (US)
StatePublished - Nov 13 2019

Keywords

  • AML

Cite this